A novel viral vaccine platform based on engineered transfer RNA

References

• Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome [research support, non-U.S. gov't]. N Engl J Med. 2003 May 15;348(20):1967–1976.
   PubMed Web of Science ®Google Scholar
• Peiris JS, Yuen KY, Osterhaus AD, et al. The severe acute respiratory syndrome [review]. N Engl J Med. 2003 Dec 18;349(25):2431–2441.
   PubMed Web of Science ®Google Scholar
• Zaki AM, van Boheemen S, Bestebroer TM, et al. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia [case reports research support, non-U.S. gov't]. N Engl J Med. 2012 Nov 8;367(19):1814–1820.
   PubMed Web of Science ®Google Scholar
• Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire ebola virus disease in Guinea [research support, non-U.S. gov't]. N Engl J Med. 2014 Oct 9;371(15):1418–1425.
   PubMed Web of Science ®Google Scholar
• Petersen LR, Jamieson DJ, Powers AM, et al. Zika virus [historical article review]. N Engl J Med. 2016 Apr 21;374(16):1552–1563.
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar;579(7798):270–273.
   PubMed Web of Science ®Google Scholar
• Ulmer JB, Valley U, Rappuoli R. Vaccine manufacturing: challenges and solutions. Nat Biotechnol. 2006 Nov;24(11):1377–1383.
   PubMed Web of Science ®Google Scholar
• Lauring AS, Jones JO, Andino R. Rationalizing the development of live attenuated virus vaccines [research support, N.I.H., extramural review]. Nat Biotechnol. 2010 Jun;28(6):573–579.
   PubMed Web of Science ®Google Scholar
• Excler JL, Saville M, Berkley S, et al. Vaccine development for emerging infectious diseases [review]. Nat Med. 2021 Apr;27(4):591–600.
   PubMed Web of Science ®Google Scholar
• Chin JW. Expanding and reprogramming the genetic code [research support, non-U.S. gov't review]. Nature. 2017 Oct 4;550(7674):53–60.
   PubMed Web of Science ®Google Scholar
• Pardi N, Hogan MJ, Porter FW, et al. mRNA vaccines – a new era in vaccinology [research support, N.I.H., extramural research support, non-U.S. gov't review]. Nat Rev Drug Discovery. 2018 Apr;17(4):261–279.
   PubMed Web of Science ®Google Scholar
• Si L, Xu H, Zhou X, et al. Generation of influenza A viruses as live but replication-incompetent virus vaccines [research support, non-U.S. gov't]. Science. 2016 Dec 2;354(6316):1170–1173.
   PubMed Web of Science ®Google Scholar
• Lin S, Yan H, Li L, et al. Site-specific engineering of chemical functionalities on the surface of live hepatitis D virus [research support, non-U.S. gov't]. Angew Chem Int Ed Engl. 2013 Dec 23;52(52):13970–13974.
   PubMed Web of Science ®Google Scholar
• Wang N, Li Y, Niu W, et al. Construction of a live-attenuated HIV-1 vaccine through genetic code expansion [research support, non-U.S. gov't]. Angew Chem Int Ed Engl. 2014 May 5;53(19):4867–4871.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Wang N, Kang G, et al. Controlling multicycle replication of live-attenuated HIV-1 using an unnatural genetic switch [research support, N.I.H., extramural research support, non-U.S. gov't]. ACS Synth Biol. 2017 Apr 21;6(4):721–731.
   PubMed Web of Science ®Google Scholar
• Zhang RR, Ye Q, Li XF, et al. Construction and characterization of UAA-controlled recombinant Zika virus by genetic code expansion [letter]. Sci China Life Sci. 2021 Jan;64(1):171–173.
   PubMed Web of Science ®Google Scholar
• Wang T-Y, Sang G-J, Wang Q, et al. Generation of premature termination codon (PTC)-harboring pseudorabies virus (PRV) via genetic code expansion technology. Viruses. 2022;14(3):572.
   PubMed Web of Science ®Google Scholar
• Lueck JD, Yoon JS, Perales-Puchalt A, et al. Engineered transfer RNAs for suppression of premature termination codons [research support, non-U.S. gov't]. Nat Commun. 2019 Feb 18;10(1):822.
   PubMedGoogle Scholar
• Wang T, Tong W, Ye C, et al. Construction of an infectious bacterial artificial chromosome clone of a pseudorabies virus variant: reconstituted virus exhibited wild-type properties in vitro and in vivo. J Virol Methods. 2018 Sep;259:106–115.
   PubMed Web of Science ®Google Scholar
• Tang YD, Na L, Zhu CH, et al. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum [research support, non-U.S. gov't]. J Virol. 2014 Nov;88(21):12296–12310.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu TX, Wang TY, et al. Isobavachalcone inhibits pseudorabies virus by impairing virus-induced cell-to-cell fusion [research support, non-U.S. gov't]. Virol J. 2020 Mar 17;17(1):39.
   PubMed Web of Science ®Google Scholar
• Yang YL, Meng F, Qin P, et al. Trypsin promotes porcine deltacoronavirus mediating cell-to-cell fusion in a cell type-dependent manner. Emerg Microbes Infect. 2020;9(1):457–468.
   PubMed Web of Science ®Google Scholar
• Zhang HL, Li YM, Sun J, et al. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species. J Biol Chem. 2021 Feb 18;296:100435.
   PubMed Web of Science ®Google Scholar
• Klupp BG, Nixdorf R, Mettenleiter TC. Pseudorabies virus glycoprotein M inhibits membrane fusion. J Virol. 2000 Aug;74(15):6760–6768.
   PubMed Web of Science ®Google Scholar
• Vallbracht M, Rehwaldt S, Klupp BG, et al. Functional relevance of the N-terminal domain of pseudorabies virus envelope glycoprotein H and Its interaction with glycoprotein L. J Virol. 2017 May 1;91(9):e00061-17.
   PubMed Web of Science ®Google Scholar
• Chen M, Wang M-H, Shen X-G, et al. Neuropilin-1 facilitates pseudorabies virus replication and viral glycoprotein B promotes its degradation in a furin-dependent manner. J Virol. 2022;96(20):e01318-22.
   PubMed Web of Science ®Google Scholar
• Chang YF, Imam JS, Wilkinson MF. The nonsense-mediated decay RNA surveillance pathway [research support, N.I.H., extramural research support, U.S. gov't, non-P.H.S. review]. Annu Rev Biochem. 2007;76:51–74.
   PubMed Web of Science ®Google Scholar
• Mattei S, Glass B, Hagen WJ, et al. The structure and flexibility of conical HIV-1 capsids determined within intact virions [research support, non-U.S. gov't]. Science. 2016 Dec 16;354(6318):1434–1437.
   PubMed Web of Science ®Google Scholar
• Chin JW. Expanding and reprogramming the genetic code of cells and animals [research support, non-U.S. gov't review]. Annu Rev Biochem. 2014;83:379–408.
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Sun SB, Furman JL, et al. A versatile platform for single- and multiple-unnatural amino acid mutagenesis in escherichia coli [research support, U.S. gov't, non-P.H.S.]. Biochemistry. 2013 Mar 12;52(10):1828–1837.
   PubMed Web of Science ®Google Scholar
• Young TS, Ahmad I, Yin JA, et al. An enhanced system for unnatural amino acid mutagenesis in E. coli [research support, U.S. gov't, non-P.H.S.]. J Mol Biol. 2010 Jan 15;395(2):361–374.
   PubMed Web of Science ®Google Scholar
• Wang K, Neumann H, Peak-Chew SY, et al. Evolved orthogonal ribosomes enhance the efficiency of synthetic genetic code expansion [research support, non-U.S. gov't]. Nat Biotechnol. 2007 Jul;25(7):770–777.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yang Q, Chen J, et al. CRISPRi-manipulation of genetic code expansion via RF1 for reassignment of amber codon in bacteria [research support, non-U.S. gov't]. Sci Rep. 2016 Jan 28;6:20000.
   PubMed Web of Science ®Google Scholar
• Schmied WH, Elsasser SJ, Uttamapinant C, et al. Efficient multisite unnatural amino acid incorporation in mammalian cells via optimized pyrrolysyl tRNA synthetase/tRNA expression and engineered eRF1 [research support, non-U.S. gov't]. J Am Chem Soc. 2014 Nov 5;136(44):15577–15583.
   PubMed Web of Science ®Google Scholar
• Pollard AJ, Bijker EM. A guide to vaccinology: from basic principles to new developments [review]. Nat Rev Immunol. 2021 Feb;21(2):83–100.
   PubMed Web of Science ®Google Scholar
• Folb PI, Bernatowska E, Chen R, et al. A global perspective on vaccine safety and public health: the global advisory committee on vaccine safety. Am J Public Health. 2004 Nov;94(11):1926–1931.
   PubMed Web of Science ®Google Scholar
• Jeyanathan M, Afkhami S, Smaill F, et al. Immunological considerations for COVID-19 vaccine strategies [research support, non-U.S. gov't review]. Nat Rev Immunol. 2020 Oct;20(10):615–632.
   PubMed Web of Science ®Google Scholar